Literature DB >> 28291000

Tailoring duration of DAPT with risk scores.

Davide Capodanno1, Dominick J Angiolillo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28291000     DOI： 10.1016/S0140-6736(17)30591-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Post-PCI Antithrombotic Treatment With High Bleeding Risk.

Authors:  Scott Kinlay
Journal:  J Am Coll Cardiol       Date:  2022-09-27       Impact factor: 27.203

Review 2.  Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention.

Authors:  Francesco Pelliccia; Felice Gragnano; Vincenzo Pasceri; Arturo Cesaro; Marco Zimarino; Paolo Calabrò
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

Review 3.  Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.

Authors:  Francesco Costa; Stephan Windecker; Marco Valgimigli
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

Review 4.  Bleeding avoidance strategies in percutaneous coronary intervention.

Authors:  Davide Capodanno; Deepak L Bhatt; C Michael Gibson; Stefan James; Takeshi Kimura; Roxana Mehran; Sunil V Rao; Philippe Gabriel Steg; Philip Urban; Marco Valgimigli; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2021-08-23       Impact factor: 32.419

5.  How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.

Authors:  Leonardo De Luca; Furio Colivicchi; Jennifer Meessen; Massimo Uguccioni; Federico Piscione; Paola Bernabò; Gerardina Lardieri; Antonino Granatelli; Domenico Gabrielli; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2019-08-31       Impact factor: 2.882

Review 6.  Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Authors:  Georges Jourdi; Anne Godier; Marie Lordkipanidzé; Guillaume Marquis-Gravel; Pascale Gaussem
Journal:  Front Cardiovasc Med       Date:  2022-01-28

Review 7.  More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions.

Authors:  Nikolaos Spinthakis; Mohamed Farag; Bianca Rocca; Diana A Gorog
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

Review 8.  Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma.

Authors:  Surya Chaturvedula; Daniel Diver; Aseem Vashist
Journal:  J Clin Med       Date:  2018-04-09       Impact factor: 4.241

9.  Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia.

Authors:  Yanan Zou; Shuang Yang; Shipeng Wang; Bo Lv; Lili Xiu; Lulu Li; Stephen W-L Lee; Chee Tang Chin; Stuart J Pocock; Yong Huo; Bo Yu
Journal:  Clin Cardiol       Date:  2020-01-22       Impact factor: 2.882
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.